Streetbeat News

Price Targets

CHRW

Stifel analyst J. Bruce Chan has maintained a 'Hold' rating on C.H. Robinson Worldwide (NASDAQ:CHRW) and lowered the price target from $91 to $86.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 6:53 pm

GXO

Stifel analyst J. Bruce Chan has maintained a 'Buy' rating on GXO Logistics (NYSE:GXO) but lowered the price target from $77 to $76.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 6:44 pm

LSTR

Stifel analyst J. Bruce Chan has maintained a 'Hold' rating on Landstar System (NASDAQ:LSTR) and lowered the price target from $185 to $177.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 6:42 pm

RXO

Stifel analyst J. Bruce Chan has maintained a 'Hold' rating on RXO (NYSE:RXO) and lowered the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 6:39 pm

SHOP

Loop Capital analyst Anthony Chukumba maintains a 'Hold' rating on Shopify (NYSE:SHOP) and lowers the price target from $62 to $57.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 6:35 pm

NKE

A significant amount of unusual options activity has been detected for Nike (NYSE:NKE), with a bearish stance being taken by a majority of investors. Of the 17 strange trades detected, 35% were bullish and 64% were bearish. The total amount for puts was $545,467 and for calls was $695,610. The price target range for Nike over the last 3 months has been between $80.0 and $105.0. The current price of NKE is up 2.57% at $102.48. Several financial institutions have given their ratings and price targets for Nike.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 6:01 pm

PFE

Pfizer Inc (NYSE:PFE) has reduced its full-year earnings and revenue guidance for 2023 due to decreasing demand for its COVID-19 products. BMO Capital Markets has lowered the price target for Pfizer from $44 to $33 with an Outperform rating. Goldman Sachs maintains a price target of $54 and sees net positives in the guidance revision. Cantor Fitzgerald suggests it's a good time to reconsider Pfizer's stock as new product launches should boost sales growth in Q4 FY23.

Portfolio Pulse from Vandana Singh

October 16, 2023 | 5:56 pm

UNH

Piper Sandler analyst Jessica Tassan maintains an Overweight rating on UnitedHealth Group (NYSE:UNH) and raises the price target from $580 to $584.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:43 pm

TSLA

Piper Sandler analyst Alexander Potter has maintained an Overweight rating on Tesla (NASDAQ:TSLA) but lowered the price target from $300 to $290.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:42 pm

RPTX

Piper Sandler analyst Joseph Catanzaro maintains an Overweight rating on Repare Therapeutics (NASDAQ:RPTX) but lowers the price target from $30 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:37 pm